Journal Home > Volume 5 , Issue 1

Over the past decades, cell surface charge, although experimentally observed, has not been well understood particularly from the viewpoint of biophysics. Our recent studies have shown that all cancer cells exhibit negative surface charges that are directly proportional to the secreted lactic acid, a unique cancer metabolic characteristic: high rate of glycolysis. We have therefore designed and developed a set of electrically-charged, fluorescent, and super-paramagnetic nanoprobes, capable of sensitive detection of cancer cells based on the surface charges. These probes are utilized to bind onto cells via electrostatic reaction for capture and magnetic separation. In this fashion, we are able to characterize cell surface charges that are regulated by different metabolic patterns, therefore effectively distinguishing the cancer cells from the normal cells. All 22 cancer cells of different organs are found to be negatively-charged therefore bound strongly by the positively-charged nanoprobes, whereas the normal cells show insignificant binding to the nanoprobes of either charge signs (positive or negative). This finding suggests that all tested cancer cells are negatively-charged and normal cells are either charge-neutral or slightly positive. For diagnosis, cancer cells can be detected, electrostatically bound, and magnetically separated in blood by charged and super-paramagnetic nanoprobes. In therapeutics, circulating cancer cells (CTCs) can be filtered and removed in a continuous fashion to reduce the risk of cancer metastasis. If successful, this new nanotechnology will revolutionize early cancer diagnosis and potentially enable new therapeutics in clinical settings.


menu
Abstract
Full text
Outline
About this article

Detection of cancer cells based on glycolytic-regulated surface electrical charges

Show Author's information Wenjun Le1Bingdi Chen1Zheng Cui1,2Zhongmin Liu1( )Donglu Shi1,3( )
The Institute for Translational Nanomedicine, Shanghai East Hospital, The Institute for Biomedical Engineering & Nano Science, School of Medicine, Tongji University, Shanghai 200092, China
Department of Pathology, School of Medicine, Wake Forest University, Winston-Salem, NC, USA
Department of Mechanical and Materials Engineering, College of Engineering and Applied Science, University of Cincinnati, Cincinnati, OH, USA

Abstract

Over the past decades, cell surface charge, although experimentally observed, has not been well understood particularly from the viewpoint of biophysics. Our recent studies have shown that all cancer cells exhibit negative surface charges that are directly proportional to the secreted lactic acid, a unique cancer metabolic characteristic: high rate of glycolysis. We have therefore designed and developed a set of electrically-charged, fluorescent, and super-paramagnetic nanoprobes, capable of sensitive detection of cancer cells based on the surface charges. These probes are utilized to bind onto cells via electrostatic reaction for capture and magnetic separation. In this fashion, we are able to characterize cell surface charges that are regulated by different metabolic patterns, therefore effectively distinguishing the cancer cells from the normal cells. All 22 cancer cells of different organs are found to be negatively-charged therefore bound strongly by the positively-charged nanoprobes, whereas the normal cells show insignificant binding to the nanoprobes of either charge signs (positive or negative). This finding suggests that all tested cancer cells are negatively-charged and normal cells are either charge-neutral or slightly positive. For diagnosis, cancer cells can be detected, electrostatically bound, and magnetically separated in blood by charged and super-paramagnetic nanoprobes. In therapeutics, circulating cancer cells (CTCs) can be filtered and removed in a continuous fashion to reduce the risk of cancer metastasis. If successful, this new nanotechnology will revolutionize early cancer diagnosis and potentially enable new therapeutics in clinical settings.

Keywords: Nanotechnology, Cancer cell, Circulating tumor cells, Cell surface charge

References(63)

Ambrose EJ, James AM, Lowick JHB, (1956) Differences between the electrical charge carried by normal and homologous tumour cells.Nature 177(4508):576

Ashworth TR, (1869) A case of cancer in which cells similar to those in the tumours were seen in the blood after death.Aust Med J 14:146

Blanks MJ, Stehle JR, Du W, Adams JM, Willingham MC, Allen GO, Hu JJ, Lovato J, Molnar I, Cui Z, (2011) Novel innate cancer killing activity in humans.Cancer Cell Int 11(1):26

Brand A, Singer K, Koehl GE, Kolitzus M, Schoenhammer G, Thiel A, Matos C, Bruss C, Klobuch S, Peter K, Kastenberger M, Bogdan C, Schleicher U, Mackensen A, Ullrich E, Fichtner-Feigl S, Kesselring R, Mack M, Ritter U, Schmid M, Blank C, Dettmer K, Oefner PJ, Hoffmann P, Walenta S, Geissler EK, Pouyssegur J, Villunger A, Steven A, Seliger B, Schreml S, Haferkamp S, Kohl E, Karrer S, Berneburg M, Herr W, Mueller-Klieser W, Renner K, Kreutz M, (2016) LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells.Cell Metab 24(5):657-671

Chaffer CL, Weinberg RA, (2011) A perspective on cancer cell metastasis.Science 331(6024):1559-1564

Chen B, Le W, Wang Y, Li Z, Wang D, Ren L, Lin L, Cui S, Hun JJ, Hu Y, Yang P, Ewing RC, Shi DL, Cui Z, (2016) Targeting negative surface charges of cancer cells by multifunctional nanoprobes.Theranostics 6(11):1887

Chikaishi Y, Yoneda K, Ohnaga T, Tanaka F, (2017) EpCAM-independent capture of circulating tumor cells with a ‘universal CTC-chip’.Oncol Rep 37(1):77-82

Colegio OR, Chu NQ, Szabo AL, Chu T, Rhebergen AM, Jairam V, Cyrus N, Brokowski CE, Eisenbarth SC, Phillips GM, Cline GW, Phillips AJ, Medzhitov R, (2014) Functional polarization of tumour-associated macrophages by tumour-derived lactic acid.Nature 513(7519):559

Copeland L , Turner JF (1980) The regulation of glycolysis and the pentose phosphate pathway. In: Davies DD (ed) Metabolism and respiration. Academic Press, New York, pp 279–316
DOI
Cui Z (2011) Granular cell anticancer therapy. Tsinghua UniversityPress, Beijing

Cui Z, Willingham MC, Hicks AM, Alexander-Miller MA, Howard TD, Hawkins GA, Miller MS, Weir HM, Du W, DeLong CJ, (2003) Spontaneous regression of advanced cancer: identification of a unique genetically determined, age-dependent trait in mice.Proc Natl Acad Sci USA 100(11):6682-6687

De Bono JS, Scher HI, Montgomery RB, Parker C, Miller MC, Tissing H, Doyle GV, Terstappen LW, Pienta KJ, Raghavan D, (2008) Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer.Clin Cancer Res 14(19):6302-6309

den Toonder J, (2011) Circulating tumor cells: the grand challenge.Lab Chip 11(3):375-377

Dubyak GR, (2004) Ion homeostasis, channels, and transporters: an update on cellular mechanisms.Adv Physiol Educ 28(4):143-154

Fu D, Mitra K, Sengupta P, Jarnik M, Lippincott-Schwartz J, Arias IM, (2013) Coordinated elevation of mitochondrial oxidative phosphorylation and autophagy help drive hepatocyte polarization.Proc Natl Acad Sci USA 110(18):7288-7293

Gadsby DC, (2009) Ion channels versus ion pumps: the principal difference, in principle.Nat Rev Mol Cell Biol 10(5):344

Gadsby DC, Takeuchi A, Artigas P, Reyes N, (2009) Peering into an ATPase ion pump with single-channel recordings.Philos Trans R Soc B 364(1514):229-238

Ghossein RA, Rosai J, (1996) Polymerase chain reaction in the detection of micrometastases and circulating tumor cells.Cancer 78(1):10-16

DOI

Ghossein RA, Scher HI, Gerald WL, Kelly WK, Curley T, Amsterdam A, Zhang ZF, Rosai J, (1995) Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications.J Clin Oncol 13(5):1195-1200

Gogichadze G, Gogichadze T, Misabishvili E, Kamkamidze G, (2014) Possible effect of variable membrane potential of a cancer cell on different carcinogenic processes.Georgian Med News 234:116-120

Gorges TM, Tinhofer I, Drosch M, Röse L, Zollner M, Krahn T, von Ahsen O, (2012) Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition.BMC Cancer 12(1):178

Haber DA, Gray NS, Baselga J, (2011) The evolving war on cancer.Cell 145(1):19-24

Hanahan D, Weinberg RA, (2011) Hallmarks of cancer: the next generation.Cell 144(5):646-674

Hatt M, Majdoub M, Vallières M, Tixier F, Le Rest CC, Groheux D, Hindié E, Martineau A, Pradier O, Hustinx R, Perdrisot R, Guillevin R, Naqa IE, Visvikis D, (2015) 18F-FDG PET uptake characterization through texture analysis: investigating the complementary nature of heterogeneity and functional tumor volume in a multi–cancer site patient cohort.J Nucl Med 56(1):38-44

Hicks AM, Riedlinger G, Willingham MC, Alexander-Miller MA, Von Kap-Herr C, Pettenati MJ, Sanders AM, Weir HM, Du W, Kim J, Simpson AJ, Old LJ, Cui Z, (2006) Transferable anticancer innate immunity in spontaneous regression/complete resistance mice.Proc Natl Acad Sci USA 103(20):7753-7758

Hosokawa M, Hayata T, Fukuda Y, Arakaki A, Yoshino T, Tanaka T, Matsunaga T, (2010) Size-selective microcavity array for rapid and efficient detection of circulating tumor cells.Anal Chem 82(15):6629-6635

Hsu PP, Sabatini DM, (2008) Cancer cell metabolism: Warburg and beyond.Cell 134(5):703-707

Hutchings M, Loft A, Hansen M, Pedersen LM, Buhl T, Jurlander J, Buus S, Keiding S, D’Amore F, Boesen A, Berthelsen AK, Lena Specht, (2006) FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma.Blood 107(1):52-59

Kim TH, Lim M, Park J, Oh JM, Kim H, Jeong H, Lee SJ, Park HC, Jung S, Kim BC, Lee K, Kim MH, Park DY, Kim GH, Cho YK, (2016) FAST: size-selective, clog-free isolation of rare cancer cells from whole blood at a liquid-liquid interface.Anal Chem 89(2):1155-1162

Kuismanen E, Saraste J, (1989) Low temperature-induced transport blocks as tools to manipulate membrane traffic.Methods Cell Biol 3:257-274

Lehrer RI, Lichtenstein AK, Ganz T, (1993) Defensins: antimicrobial and cytotoxic peptides of mammalian cells.Annu Rev Immunol 11(1):105-128

Li P, Mao Z, Peng Z, Zhou L, Chen Y, Huang PH, Truica CI, Drabick JJ, El-Deiry WS, Dao M, Suresh S, Huang TJ, (2015) Acoustic separation of circulating tumor cells.Proc Natl Acad Sci USA 112(16):4970-4975

Lu J, Tan M, Cai Q, (2015) The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism.Cancer Lett 356(2):156-164

McLaughlin PJ, (1954) A history of the theories of aether and electricity.Philos Stud 4:118-119

Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, Stein KD, Alteri R, Jemal A, (2016) Cancer treatment and survivorship statistics.CA: A Cancer J Clin 66(4):271-289

Moon HS, Kwon K, Kim SI, Han H, Sohn J, Lee S, Jung HI, (2011) Continuous separation of breast cancer cells from blood samples using multi-orifice flow fractionation (MOFF) and dielectrophoresis (DEP).Lab Chip 11(6):1118-1125

Nagrath S, Sequist LV, Maheswaran S, Bell DW, Irimia D, Ulkus L, Simth MR, Kwak EL, Diagumarthy S, Muzikansky A, Ryan P, Balis UJ, Tompkin RG, Haber DA, Toner M, (2007) Isolation of rare circulating tumour cells in cancer patients by microchip technology.Nature 450(7173):1235

Osaka T, Nakanishi T, Shanmugam S, Takahama S, Zhang H, (2009) Effect of surface charge of magnetite nanoparticles on their internalization into breast cancer and umbilical vein endothelial cells.Colloids Surf, B 71(2):325-330

Pestonjamasp VK, Mehta NG, (1995) Erythrocytes from Yoshida ascites sarcoma-bearing rats have reduced surface charge: the effect of tumor products.Cancer Biochem Biophys 15(1):19-23

Plaks V, Koopman CD, Werb Z, (2013) Circulating tumor cells.Science 341(6151):1186-1188

Pore M, Meijer C, de Bock GH, Boersma-van Ek W, Terstappen LW, Groen HJ, Timens W, Kruyt FAE, Hiltermann TJN, (2016) Cancer stem cells, epithelial to mesenchymal markers, and circulating tumor cells in small cell lung cancer.Clin Lung Cancer 17(6):535-542

Purdom L, Ambrose EJ, Klein G, (1958) A correlation between electrical surface charge and some biological characteristics during the stepwise progression of a mouse sarcoma.Nature 181(4623):1586

Racila E, Euhus D, Weiss AJ, Rao C, McConnell J, Terstappen LW, Uhr JW, (1998) Detection and characterization of carcinoma cells in the blood.Proc Natl Acad Sci USA 95(8):4589-4594

Radovic-Moreno AF, Lu TK, Puscasu VA, Yoon CJ, Langer R, Farokhzad OC, (2012) Surface charge-switching polymeric nanoparticles for bacterial cell wall-targeted delivery of antibiotics.ACS Nano 6(5):4279-4287

Riedlinger G, Adams J, Stehle JR, Blanks MJ, Sanders AM, Hicks AM, Willingham MC, Cui Z, (2010) The spectrum of resistance in SR/CR mice: the critical role of chemoattraction in the cancer/leukocyte interaction.BMC Cancer 10(1):179

Schell JC, Olson KA, Jiang L, Hawkins AJ, Van Vranken JG, Xie J, Egnatchik RA, DeBeradinis RJ, Rutter J, (2014) A role for the mitochondrial pyruvate carrier as a repressor of the Warburg effect and colon cancer cell growth.Mol Cell 56(3):400-413

Siegel RL, Miller KD, Jemal A, (2017) Cancer statistics, 2017.CA: A Cancer J Clin 67:7-30

Siegel RL, Miller KD, Jemal A, (2018) Cancer statistics, 2008.Ca: A Cancer J Clin 68:5-29

Sonders MS, Amara SG, (1996) Channels in transporters.Curr Opin Neurobiol 6(3):294-302

Stewart B, Wild CP (2014) World cancer report 2014
DOI

Tellez-Gabriel M, Brown HK, Young R, Heymann MF, Heymann D, (2016) The challenges of detecting circulating tumor cells in sarcoma.Front Oncol 6:202

Vander Heiden MG, Cantley LC, Thompson CB, (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation.Science 324(5930):1029-1033

Vassar PS, (1963) Electrophoretic mobility of human tumour cells.Nature 197(4873):1215-1216

Vyas S, Zaganjor E, Haigis MC, (2016) Mitochondria and cancer.Cell 166(3):555-566

Warburg O, (1924) Über den stoffwechsel der carcinomzelle.Naturwissenschaften 12(50):1131-1137

Warburg O, (1956) On the origin of cancer cells.Science 123(3191):309-314

Yoon HJ, Kim TH, Zhang Z, Azizi E, Pham TM, Paoletti C, Lin J, Ramnath N, Wicha MS, Hayes DF, Simeone DM, Nagrath S, (2013) Sensitive capture of circulating tumour cells by functionalized graphene oxide nanosheets.Nat Nanotechnol 8(10):735

Yoshii T, Geng Y, Peyton S, Mercurio AM, Rotello VM, (2016) Biochemical and biomechanical drivers of cancer cell metastasis, drug response and nanomedicine.Drug Discov Today 21(9):1489-1494

You JS, Jones PA, (2012) Cancer genetics and epigenetics: two sides of the same coin?.Cancer Cell 22(1):9-20

Yu M, Bardia A, Wittner BS, Stott SL, Smas ME, Concannon KF, (2013) Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition.Science 339:580-584

Yu M, Bardia A, Aceto N, Bersani F, Madden MW, Donaldson MC, Desai R, Zhu H, Comaills V, Zheng Z, Wittner BS, Petar Stojanov, Brachtel E, Sgroi D, Kapur R, Shioda T, Ting DT, Ramaswamy S, Getz G, Iafrate AJ, Benes C, Toner M, Maheswaran S, Harber D, (2014) Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility.Science 345(6193):216-220

Zink D, Fischer AH, Nickerson JA, (2004) Nuclear structure in cancer cells.Nat Rev Cancer 4(9):677

Williams SCP, (2013) Circulating tumor cells.Proc Natl Acad Sci USA 110(13):4861-4861

Publication history
Copyright
Acknowledgements
Rights and permissions

Publication history

Received: 29 May 2018
Accepted: 27 August 2018
Published: 01 March 2019
Issue date: February 2019

Copyright

© The Author(s) 2019

Acknowledgements

Acknowledgement

This study was supported by National Natural Science Foundation of China (31671029, 81772285), Shanghai Natural Science Foundation (16ZR1400700), National Postdoctoral Program for Innovation Talents (BX201700173), and China Postdoctoral Science Foundation (2017M621534).

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Return